Viridian Therapeutics, Inc. (VRDN)
17.62
+0.17
(+0.97%)
USD |
NASDAQ |
May 29, 16:00
17.82
+0.20
(+1.14%)
After-Hours: 20:00
Viridian Therapeutics Shareholders Equity (Quarterly) : 636.01M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Amgen, Inc. | 9.19B |
| Spyre Therapeutics, Inc. | 670.81M |
| Praxis Precision Medicines, Inc. | 1.410B |
| CAMP4 Therapeutics Corp. | 30.90M |
| Savara, Inc. | 176.04M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 789.02M |
| Total Liabilities (Quarterly) | 153.01M |
| Debt to Equity Ratio | 0.0805 |
| Current Ratio | 15.15 |
| Net Debt Paydown Yield | -0.28% |